ArticleMolecules (Basel, Switzerland)2025
Sugarcane Straw Hemicellulose Extraction by Autohydrolysis for Cosmetic Applications.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Sugarcane is a popular crop whose cultivation generates a wide range of by-products. The aim was to optimize the hydrothermal extraction of hemicellulose from sugarcane straw using response-surface methods with a two-factor composite design and to assess its functional qualities. Three process parameters were subject to optimization: solid/liquid ratio (1:6-1:18), temperature (143-186 °C), and extraction time (20-60 min). A xylooligosaccharide (XOS)-enriched extract was characterized regarding its chemical composition, molecular weight, and antioxidant and antimicrobial potential. The optimized extraction yield was 24.46 g/100 g of straw with a polymerization degree of 17.40. Both hemicellulose and XOS demonstrated notable antioxidant properties, with antioxidant effects of 73% and 85%, respectively. Regarding skin enzyme activity, hemicellulose inhibited elastase by more than 50%, while XOS showed no significant effect. However, both extracts exhibited collagenase (MMP1) inhibition comparable to the positive control. In terms of production feasibility, the estimated costs were 130.5 EUR/kg for hemicellulose and 272.5 EUR/kg for XOS. Overall, the optimized XOS-enriched sugarcane straw extract demonstrated promising anti-aging, antioxidant, and preservative properties, highlighting its potential for cosmetic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.